Loading clinical trials...
Loading clinical trials...
REAL: A Pre-/Post-Intervention Descriptive Analysis and Cross-Sectional Survey to Evaluate Real-World Treatment Outcomes, Consumption, and Satisfaction With Damoctocog Alfa Pegol in US Hemophilia Treatment Centers
Conditions
Interventions
No intervention
Locations
3
United States
University of California, Davis
Sacramento, California, United States
Tulane University
New Orleans, Louisiana, United States
Regents of the University of Minnesota
Minneapolis, Minnesota, United States
Start Date
January 17, 2023
Primary Completion Date
November 6, 2023
Completion Date
November 6, 2023
Last Updated
November 28, 2023
NCT07226206
NCT05987449
NCT04645199
NCT06703606
NCT06702579
NCT03818763
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions